Immediate Impact

56 standout
Sub-graph 1 of 23

Citing Papers

Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
2025 Standout
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
2025 Standout
2 intermediate papers

Works of Ştefan Chiriac being referenced

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
2023
Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
2021

Author Peers

Author Last Decade Papers Cites
Ştefan Chiriac 318 155 187 53 629
Shobha Joshi 342 345 189 28 668
Felix Gundling 225 203 291 76 635
Chetan Mittal 159 83 216 36 628
Elroy Patrick Weledji 91 57 368 68 726
Pamela L. Valentino 308 255 297 39 614
S Wapnick 126 175 375 59 727
Jeremiah P. Donovan 328 241 260 27 649
André Weigert 220 283 189 57 663
Louis Ho Shing Lau 85 44 232 36 563
Hale Akpınar 218 70 259 45 695

All Works

Loading papers...

Rankless by CCL
2026